News & Events
July 31, 2015
The conversion from ICD-9 to ICD-10 is quickly approaching and will go into effect on October 1, 2015 – just two months away! PathGroup is working diligently towards implementation and will be equipped to support the new code set come October. PathGroup is actively working to integrate all systems and resources, and encourage our clients to do the same.
Click Here to read more.
This change will take effect July 20, 2015
Overview and Clinical Utility:
Effective July 20, 2015, PathGroup will no longer perform testing for OVA1, a proprietary Aspira Labs assay used for the evaluation of ovarian masses. To avoid disruption in services, PathGroup will manage orders for OVA1 testing through a Third Party Phlebotomy Agreement.
Click Here to read more.
This change will take effect immediately
Overview and Clinical Utility:
Effective immediately, PathGroup will implement a new single transport system, Parasep® SF Patient Care Pack, for fecal collection and transport of specimens for Ova and Parasite Fecal Examination. The one-vial system, distinguishable by its green cap and AlcorFix contents, will replace the two-vial blue and pink Para-Pak® collection containers.
Click Here to read more.
This change will take effect June 29, 2015
Overview and Clinical Utility:
Effective June 29, 2015 PathGroup Labs will begin offering the non-invasive Echosens FibroMeter diagnostic test for liver fibrosis and inflammation. This addition provides clients with superior testing results and improved turnaround time. In addition to current chemistry assays, FibroMeter utilizes two supplementary tests, platelet count and prothrombin index, to result a fibrosis, cirrhosis, and activity score.
Click Here to read more.
June 24, 2015
Summer is officially here and temperatures are heating up! PathGroup would like to remind all clients that specimens must be kept from extreme temperatures in order to provide optimal stability and validity for patient results. To preserve specimen stability during the summer months, PathGroup recommends specimens be placed in the lockbox 30 minutes before your scheduled courier pick up or as close to your scheduled pick up time as possible. Purple top tubes for Complete Blood Count (CBC) analysis, in particular, must be kept cool.
Click Here to read more.
June 23, 2015
The Centers for Medicare and Medicaid Services (CMS) mandated conversion from the International Classification of Diseases 9th Revision (ICD-9) to the International Classification of Diseases 10th Revision (ICD-10) will go into effect October 1, 2015. Physicians, insurance providers, EHR/EMR vendors, and laboratories are just some of those preparing to implement the new code set. PathGroup is no exception. With the deadline quickly approaching, we are working diligently to facilitate a smooth transition for our clients.
Click Here to read more.
This change will take effect June 8, 2015
Overview and Clinical Utility:
Effective June 8, 2015 PathGroup Labs will no longer report critical values for Prothrombin Time (PT) due to international normalized ratio (INR) values minimizing the variation between reagents. This will also improve quality of laboratory monitoring of oral anticoagulant therapy.
Click Here to read more.
This change will take effect April 27, 2015
Overview and Clinical Utility:
Effective April 27, 2015, PathGroup will implement updated specimen collection requirements for Serum Iodine testing. As a result, plasma is no longer an acceptable specimen of choice for Serum Iodine testing.
Click Here to read more.
Overview and Clinical Utility:
PathGroup’s 25-Hydroxy Vitamin D assay, test code VD25H, measures both vitamin D2 and D3 forms of 25-hydroxy Vitamin D, which is the major compound produced in the liver. To properly assess and measure vitamin D status, 25-hydroxy Vitamin D is the test of choice.
Click Here to read more.
This change will take effect March 26, 2015
Overview and Clinical Utility:
Effective March 26, 2015, PathGroup will update current hematology testing methodology to provide enumeration of immature granulocytes (IG) with all standard differential counts. All metamyelocytes, myelocytes, and promyelocytes will be counted and reported cumulatively as part of the automated differential resulting system (6-part automated differential).
Click Here to read more.
